Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07312903
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed solid tumor and tumor types known to be Wnt-pathway activated (such as colorectal cancer, gastric cancer, lung cancer, and triple negative breast cancer) and no other approved treatment options available.
* At least one measurable target lesion as defined by RECIST v1.1 on CT, PET/CT, or MRI.
* ECOG performance status of 0 or 1.
* Physiological conditions that may prevent absorption of an oral medication including but not limited to colostomy and ileostomy.
* Age ≥18 years (or ≥ age of majority per local regulation)
* Life expectancy ≥3 months
* Willing and able to comply with protocol requirements
Exclusion Criteria:
* Symptomatic or uncontrolled brain metastasis requiring concurrent treatment,
* Another known malignancy that is progressing or requires active treatment within the last 2 years (except basal cell carcinoma, in situ cervical cancer, etc.).
* Inadequate organ function
* Known hypersensitivity to study drug or excipients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07312903
Study Brief:
Protocol Section:
NCT07312903